CoChat

Common Variation in the DIO2 Gene Predicts Baseline Psychological Well-Being and Response to Combination Thyroxine Plus Triiodothyronine Therapy in Hypothyroid Patients

Open access

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Introduction: Animal studies suggest that up to 80% of intracellular T3 in the brain is derived from circulating T4 by local deiodination. We hypothesized that in patients on T4 common variants in the deiodinase genes might influence baseline psychological well-being and any improvement on combined T4/T3 without necessarily affecting serum thyroid hormone levels. Methods: We analyzed common variants in the three deiodinase genes vs. baseline psychological morbidity and response to T4/T3 in 552 subjects on T4 from the Weston Area T4 T3 Study (WATTS). Primary outcome was improvement in psychological well-being assessed by the General Health Questionnaire 12 (GHQ-12). Results: The rarer CC genotype of the rs225014 polymorphism in the deiodinase 2 gene (DIO2) was present in 16% of the study population and was associated with worse baseline GHQ scores in patients on T4 (CC vs. TT genotype: 14.1 vs. 12.8, P = 0.03). In addition, this genotype showed greater improvement on T4/T3 therapy compared with T4 only by 2.3 GHQ points at 3 months and 1.4 at 12 months (P = 0.03 for repeated measures ANOVA). This polymorphism had no impact on circulating thyroid hormone levels. Conclusions: Our results require replication but suggest that commonly inherited variation in the DIO2 gene is associated both with impaired baseline psychological well-being on T4 and enhanced response to combination T4/T3 therapy, but did not affect serum thyroid hormone levels.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2008-1301

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Research works printed but not linked: 1

  1. Levitt, 2002, T4 plus T3 for hypothyroidism: a double-blind comparison with usual T4, 4

Cited by

See all 327

Metadata

Authors
Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M.
Affiliations
  • The University of Western Australia (AU)
  • University of Bristol (GB)
  • Royal Devon and Exeter Hospital (GB)
  • University of Exeter (GB)
Corresponding author
Dayan, Colin M.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2009-05-01
Volume
94
Issue
5
Pages
1623-1629
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2059487357
Cited by
327
References
39
Citations by year
2026: 9 · 2025: 12 · 2024: 10 · 2023: 23 · 2022: 27 · 2021: 23 · 2020: 15 · 2019: 25 · 2018: 22 · 2017: 21 · 2016: 25 · 2015: 22 · 2014: 19 · 2013: 21 · 2012: 21
FWCI
12.34
Type
journal article
Language
en
Licence
other-oa
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
deiodinase 2, triiodothyronine, thyroxine, hypothyroidism, combination thyroid hormone therapy, genetic polymorphism, psychological well-being, treatment response, GHQ-12, serum thyroid hormones
MeSH terms
Iodothyronine Deiodinase Type II, Adult, DNA, Female, Genotype, Health Status, Humans, Hypothyroidism, Iodide Peroxidase, Male, Polymorphism, Genetic, Predictive Value of Tests, Psychometrics, Surveys and Questionnaires, Thyroid Function Tests, Thyrotropin, Thyroxine, Triiodothyronine, Genetic Variation, Hormone Replacement Therapy, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.